Skip to main content
Clinical Trials/NL-OMON21716
NL-OMON21716
Not yet recruiting
Not Applicable

The effect of nutritional supplementation as adjunct to exercise training on resting and exercise-induced oxidative stress, muscle function and exercise capacity in severe COPD patients.

AMWJ Schols, Prof Director NUTRIMUniversity MaastrichtPostbus 6166200 MD Maastrichtthe Netherlands0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD, supplementation, antioxidants, rehabilitationCOPD, supplementatie, antioxidatnen, revalidatie
Sponsor
AMWJ Schols, Prof Director NUTRIMUniversity MaastrichtPostbus 6166200 MD Maastrichtthe Netherlands
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
AMWJ Schols, Prof Director NUTRIMUniversity MaastrichtPostbus 6166200 MD Maastrichtthe Netherlands

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of COPD according to the American Thoracic Society (ATS) GOLD guidelines (FEV1 \< 60% predicted and FEV1/FVC \< 70% and \< 10% predicted improvement in FEV1 after b2\-agonist inhalation (14, 15\));
  • 2\. Both male and female, age\-range from 40 to 75 years;
  • 3\. No respiratory tract infection or exacerbation of the disease for at least 4 weeks before the study;
  • 4\. Capable to provide informed consent;
  • 5\. Presence of other chronic diseases is allowed in case the clinical status is stable for at least 4 weeks before the study.

Exclusion Criteria

  • 1\. Inability to perform the incremental cycle ergometer test;
  • 2\. Chronic use of antioxidants or vitamin supplements;
  • 3\. Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements;
  • 4\. Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study;
  • 5\. Specific allergy or intolerance.

Outcomes

Primary Outcomes

Not specified

Similar Trials